Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.

Cem OnalFatih KoseGokhan OzyigitSercan AksoyEzgi OymakSadik MuallaogluOzan C GulerBurak TilkiPervin HurmuzFadil Akyol

Published in: The Prostate (2021)

MDT for oligoprogressive lesions is effective and may provide several benefits compared to switching from ARTA treatment to NEST. Patients with early progression while on ARTAs and inadequate PSA responses after MDT have a greater risk of rapid disease progression and poor survival, which necessitates intensified treatment.

Keyphrases

prostate cancer
squamous cell carcinoma
small cell lung cancer
end stage renal disease
combination therapy
ejection fraction
quantum dots
radiation induced
loop mediated isothermal amplification